Masanday, Kairi .

HRN: 25-57-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
03/06/2025
03/12/2025
ORAL
2.5ml
Q12
PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: